调节性T细胞对免疫性血小板减少症患者糖皮质激素敏感性的预测价值:多中心前瞻性临床研究
该多中心前瞻性研究纳入55例初诊ITP患者和44名健康志愿者,患者接受糖皮质激素治疗2周后按疗效分为敏感组与不敏感组。
核心结论
- CD8+ CD25str+ Tregs及其亚群水平对判断ITP患者对糖皮质激素的敏感性具有预测价值。
研究设计与样本
- 多中心前瞻性临床研究,从七家医院纳入55例初诊ITP患者和44名健康志愿者。
- 所有患者接受GC治疗,治疗2周后根据疗效分为GC敏感组和不敏感组。
主要发现
- CD4+ Tregs水平无明显变化。
临床怎么用
- 可考虑检测CD8+ CD25str+ Tregs水平及其亚群,辅助预判初诊ITP患者对GC治疗的敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glucocorticoids (GC) are used as the first-line treatment of immune thrombocytopenia (ITP), but 10-20% of patients are insensitive to them. Regulatory T cells (Tregs) can maintain immune tolerance in autoimmune diseases. The present research pooled 55 patients with newly diagnosed ITP and 44 healthy volunteers from seven hospitals. All patients received GC treatment and were divided into GC-sensitive and GC-insensitive groups according to the curative effect after 2 weeks of treatment. The levels of lymphocyte subgroups and Tregs were recorded. As the results indicated, the levels of CD8+ CD25str+ Tregs in the GC-sensitive group were significantly higher than that of the GC-insensitive group (P = 0·005). The optimal critical value of CD8+ CD25str+ Tregs to distinguish GC sensitivity was 0·09%. With GC therapy the level of CD45RO+ /CD8+ CD25str+ Tregs (activated type) decreased after treatment (P = 0·02) and the level of CD45RO- /CD8+ CD25str+ Tregs (initial type) increased slightly (P = 0·11). There were no obvious changes in the level of CD4+ Tregs. These findings support that the level of CD8+ CD25str+ Tregs and its subgroups have a predictive value in judging the sensitivity to GC among patients with ITP. Trial registration: www.chictr.org.cn; ChiCTR-OON-17014165.
引用
- Li L, Zhao Y, Tong X, et al. The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study. Br J Haematol. 2021. PMID: 33690890. doi:10.1111/bjh.17368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。